9:00 AM09:00

Health Technology Assessment in Medical Devices



Industry (Pharmaceutical/ Medical device/ Consultancy): $500
Healthcare professional/ Academia/ Public institutions: $250
Students: $150

Limited slots (40) are available for the workshop.

Health Technology Assessment in Medical Devices Workshop
from 150.00
Sign up now
View Event →
to Jul 25

Workshop: Conducting Economic Evaluation using Person-level Data

The Health Intervention and Policy Evaluation Research (HIPER) & Singapore Population Health Improvement Centre (SPHERiC) will be organising an enriching event with the following details:

Title: Conducting Economic Evaluation using Person-level Data

Date: 24 and 25 July 2019
Venue: Computer Lab 2 (Level 8)Tahir Foundation Building (MD1), 12 Science Drive 2, Singapore 117549

You may find more details and register at the following link:

We look forward to seeing you!

View Event →
6:30 PM18:30

ISPOR-S Extraordinary General Meeting

Event summary for ISPOR-S Extraordinary General Meeting

26th Feb 2019

The extraordinary meeting was attended by 16 ISPOR-S members on 26th February 2019.
The evening was graced by Professor Jaime Cairo, Chief Scientist, Evidera, who challenged ISPOR-S with the prospects of health economics and outcomes research. He shared that as patients become more involved and informed of their health and treatment options, payers and health providers would need to better position themselves to elaborate on the the value of health interventions and outcomes. 

The ISPOR-S work plan 2019 was also shared by the Chapter’s President, Assistant Professor Wee Hwee Lin. The Chapter would see collaborations with HTAsiaLink and National University of Singapore Saw Swee Hock School of Public Health to develop guidance on real world evidence collection in health technology assessment. In addition, a collaboration with the Pharmaceutical Society of Singapore is established to promote understanding of health economics and outcomes research among pharmacists in Singapore. Future Chapter events include a health technology assessment in medical devices with an aim to develop an understanding of the complexities of conducting economic evaluation of medical devices.

The fruitful evening was then concluded with a commentary on drug/device value propositions in a universal health coverage world by Mr. Chris Hardesty, Director, KPMG Singapore Life Sciences.

This is a past event.

This event is open ONLY to members of the ISPOR-S and invited guests.

To join ISPOR-S as a member, click here

View Event →